T-Mobile reports Q1 beat, takes a bite into Verizon, AT&T >>> READ MORE


Why the Amgen, Inc. (AMGN) Patent Case Is So Important

Amgen (AMGN) is pursuing a court case that will force the legal system to make a decision that will essentially become statute. More 

Pfizer Inc. (PFE), Lockheed Martin (LMT) Get “Trumped”

Pfizer (PFE) and Lockheed Martin (LMT) were among the stocks that were rattled Wednesday during Donald Trump's press conference. More 

Should You Buy Amgen Inc. (AMGN) Stock? 3 Pros, 3 Cons

AMGN stock has started 2017 with solid gains. But has Repatha gotten Amgen stock back on track, or will biotech weakness rear its head again? More 

SPDR S&P Biotech (ETF) (XBI): Get on Board the Biotech Train!

Biotech stocks have gained the wind, but the SPDR S&P Biotech (ETF) (XBI) hasn't yet caught up with the market. That's going to change soon. More 

3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Gap Inc (GPS) and PriceSmart, Inc. (PSMT)

Amgen (AMGN) won a key patent dispute, Gap (GPS) posts strong holiday sales and PriceSmart (PSMT) profit rises ahead of Friday's trading. More 

3 Stocks to Watch on Wednesday: Tesla Motors Inc (TSLA), Agile Therapeutics Inc (AGRX) and Regeneron Pharmaceuticals Inc (REGN)

Tesla Motors (TSLA) dips on a vehicle deliveries miss, Agile Therapeutics (AGRX) tanks on trial results and Regeneron (REGN) suffers a legal defeat. More 

6 Dividend Stocks Increasing Payouts — AMGN CVS MCO FITB BXP CHH

Six notable dividend stocks raised their payouts last week, including Amgen (AMGN) and CVS Health (CVS). Here's what you need to know. More